SBC Medical Group Holdings (SBC) AI Stock Analysis

• Market Cap: $320.77M
• Dividend Yield: N/A
• Average Volume (3M): 23.30K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.83
• Revenue Growth: N/A
• EPS Growth: -1484.62%
• Country: US
• Employees: 863
• Sector: Financial
• Sector Strength: 87
• Industry: Consulting Services
• EPS (TTM): -0.02
• Shares Outstanding: 103,611,250
• 10 Day Avg. Volume: 18,919
• 30 Day Avg. Volume: 23,297
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): 0.00
• Price to Cash Flow (P/CF): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: 1.43
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: 3.34
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

SBC Medical Group Holdings demonstrates robust financial performance with strong profitability and financial stability, though cash flow management needs improvement. The technical analysis indicates a bearish trend, while valuation metrics are concerning due to the negative P/E ratio. The recent investment in Bitcoin represents a strategic diversification move, enhancing long-term stability.

SBC Medical Group Holdings Business Overview & Revenue Model

Company Description

SBC Medical Group Holdings (SBC) is a healthcare services provider focusing on delivering integrated medical solutions across various sectors, including primary care, specialty care, and outpatient services. The company operates a network of clinics and healthcare facilities that offer a comprehensive range of medical services aimed at enhancing patient care and healthcare outcomes.

How the Company Makes Money

SBC generates revenue primarily through patient services, including consultations, diagnostic procedures, and treatments provided across its network of clinics and facilities. The company also benefits from partnerships with insurance providers, securing reimbursements for services rendered to insured patients. Additionally, SBC may engage in collaborations with pharmaceutical companies and research institutions to conduct clinical trials or health studies, which can serve as another revenue stream. Other factors contributing to its earnings may include government healthcare programs and private payers, which help maintain a stable cash flow.

SBC Medical Group Holdings Financial Statement Overview

Summary

SBC faces significant financial challenges with negative equity and poor cash flow. While there are some operational improvements, these financial weaknesses overshadow them, necessitating strategic changes.

Income Statement

The income statement lacks key revenue data, making it difficult to assess overall performance. However, the company shows some improvement in EBIT and EBITDA from the previous year, indicating potential operational efficiency. Net income declined, which suggests challenges in profitability.

Balance Sheet

The balance sheet reveals a concerning negative stockholders' equity, indicating financial instability. High liabilities relative to equity and a negative equity position pose significant risks. The debt-to-equity ratio cannot be calculated due to negative equity, further underscoring financial weaknesses.

Cash Flow

The cash flow statement highlights severe issues, with negative operating and free cash flows, signaling cash management challenges. The significant fluctuation in financing and investing cash flows between periods suggests potential liquidity risks and inconsistent financial strategies.

Breakdown
Dec 2023	Dec 2022
Income Statement		Total Revenue
193.54M	174.16M
	Gross Profit
137.30M	114.83M
	EBIT
70.66M	20.12M
	EBITDA
85.87M	29.64M
	Net Income Common Stockholders
39.37M	6.32M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
103.02M	53.64M
	Total Assets
258.81M	225.48M
	Total Debt
22.87M	16.13M
	Net Debt
-80.16M	-35.61M
	Total Liabilities
115.00M	117.63M
	Stockholders Equity
142.16M	105.25M
Cash Flow		Free Cash Flow
39.44M	-24.99M
	Operating Cash Flow
50.64M	-47.37K
	Investing Cash Flow
1.82M	-32.65M
	Financing Cash Flow
6.14M	-7.98M

SBC Medical Group Holdings Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 3.10
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SBC, the sentiment is Negative. The current price of 3.1 is below the 20-day moving average (MA) of 3.65, below the 50-day MA of 3.73, and below the 200-day MA of 7.00, indicating a bearish trend. The MACD of -0.13 indicates Positive momentum. The RSI at 36.95 is Neutral, neither overbought nor oversold. The STOCH value of 1.60 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SBC.

SBC Medical Group Holdings Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CRAI	75 Outperform	$1.13B	22.50	23.18%	1.09%	8.49%	21.06%
Sector *	64 Neutral	$12.61B	9.78	8.01%	16985.69%	12.73%	-4.58%
SBC	61 Neutral	$320.77M	―	8.36%	―	―	-1484.62%
FC	60 Neutral	$275.21M	15.96	24.81%	―	2.53%	5.95%
AERT	57 Neutral	$30.40M	0.43	112.00%	―	34.17%	―
FORR	50 Neutral	$181.46M	―	-2.45%	―	-10.05%	-288.36%
RGP	49 Neutral	$192.46M	―	-31.18%	9.62%	-16.27%	-589.83%

SBC Medical Group Holdings Corporate Events

SBC Medical Group Invests 1 Billion Yen in Bitcoin

On February 12, 2025, SBC Medical Group Holdings announced its decision to purchase Bitcoin, with a planned investment of 1 billion yen through Coinbase, Inc. This move is part of SBC Medical’s strategic initiative to strengthen its financial base and support long-term enterprise value through asset diversification. By investing in Bitcoin, the company aims to leverage cryptocurrencies as a hedge against inflation and enhance its financial stability. The decision highlights SBC Medical’s commitment to flexible financial strategies and transparency in operations, aiming to strengthen trust with shareholders and stakeholders.